Day: September 12, 2025

Appoints Veteran Luxury and Spirits Marketer Tina Reejsinghani as CMO to Lead Next Phase of Brand Growth NORWALK, Conn., Sept. 12, 2025 (GLOBE NEWSWIRE) — Reed’s, Inc. (OTCQX: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, natural ginger beverages, today announced a series of organizational and leadership updates aimed to enhance its operational efficiency and position the Company for long-term success. Following a careful evaluation of its organizational structure and long-term priorities, Reed’s has concluded that a corporate reorganization was necessary. This step, while not taken lightly, is part of a broader strategic realignment designed to strengthen the Company’s foundation for future growth. In tandem with this effort, Reed’s is advancing key investments to bolster its commercial...

Dr. Barbara Klencke is an accomplished clinical leader with a distinguished track record in oncology drug development who currently serves on the Company’s Board of Directors and will step down from the Board to join ALX as Interim Chief Medical Officer Alan Sandler, M.D. resigns as Chief Medical Officer and will return to his position serving on the Company’s Board of DirectorsSOUTH SAN FRANCISCO, Calif., Sept. 12, 2025 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, today announced the appointment of Dr. Klencke to the role of Interim Chief Medical Officer (CMO) on a full-time basis. Dr. Alan Sandler is departing from the role of CMO and will...

JENA, Germany, Sept. 12, 2025 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system (the “Company”), today announced that it has received a written notice (the “Notice”), dated September 11, 2025, from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with Nasdaq’s minimum bid price requirement set forth under Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”). According to the Notice, the Company regained compliance with the Minimum Bid Price Requirement because the closing bid price of the Company’s ordinary shares has been $1.00 per share or greater for 10 consecutive business days, from August 27, 2025 to September 10, 2025, and...

NEW YORK, Sept. 12, 2025 (GLOBE NEWSWIRE) — NASDAQ-listed Blue Hat Interactive Entertainment Technology Inc. (BHAT) announced that it completed over 123KG (US$13,326,754) in gold trading during the first half of 2025, and projects that trading volume may potentially reach 550KG during fiscal year 2025, subject to market conditions. “This represents progress in the company’s strategic transformation toward gold-focused commodity trading,” stated Mr. Chen Xiaodong, CEO of the company. He further noted: “Mainland China represents one of the world’s largest gold consumption markets. China and India’s gold consumption demand reportedly accounts for over 50% of the global market. Gold is a distinctive commodity with both commercial and monetary attributes. Beyond generating profits through trading,...

TORONTO, Sept. 12, 2025 (GLOBE NEWSWIRE) — DPM Metals Inc. (TSX: DPM) (“DPM” or “the Company”) is pleased to announce that it has completed its name change to DPM Metals Inc. from Dundee Precious Metals Inc. effective September 12, 2025, following receipt of requisite shareholder approval at its special meeting of shareholders held August 13, 2025. David Rae, President & CEO of DPM commented: “Our name, DPM Metals, represents an important step in differentiating our business going forward. We are building on our long track record and well-established brand of successful exploration, project development and exceptional operational delivery from resourceful, acquisitive roots. “Our core capabilities form a strong foundation for responsible, efficient production and project development. These characteristics will continue to...

TORONTO, Sept. 12, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development, today announced its licensee – Unbuzzd Wellness Inc. (the “Company” or “Unbuzzd“), the company behind unbuzzdTM — the scientifically-proven and game-changing beverage that accelerates alcohol metabolism, restores mental clarity and reduces hangover symptoms, will host an Investor Webinar on Tuesday, September 16, 2025 at 1:30 p.m. Pacific time, 4:30 p.m. Eastern Standard Time. During...

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES (Note: All dollar amounts in this news release are expressed in U.S. dollars except as otherwise noted.) TORONTO, Sept. 12, 2025 (GLOBE NEWSWIRE) — Fairfax India Holdings Corporation (“Fairfax India” or the “Company”) (TSX: FIH.U) announces that its wholly-owned subsidiary, FIH Mauritius Investments Ltd has entered into an agreement to sell its 51% equity interest in Saurashtra Freight Private Limited (“Saurashtra”) to Kamigumi Co., Ltd., a Japanese logistics company for INR 6,622 million (approximately US$75 million at current exchange rates). The transaction is subject to customary closing conditions and approvals and is expected to close in the fourth quarter of 2025. Upon closing of the transaction, Fairfax India will cease to own any shares...